Enzolytics Inc (ENZC)

[OTCShotCaller]

Great post by J5150 that fully describes what happened with BTG and I'll paste that here for discussion purposes.:

"BTG is an intellectual property and technology commercialisation company that operates internationally. BTG creates value by investing in intellectual property and technology development, and in early stage ventures. We realise value through technology licensing, patent assertion and sale of equity investments. Through a multidisciplinary approach, we apply intellectual property and commercial expertise, together with specialist skills in science and technology, to create major product opportunities in the health and high tech sectors. BTG has commercialised important innovations, including Magnetic Resonance Imaging, Multilevel Cell Memory, Campath (alemtuzumab), the first monoclonal antibody treatment for chronic lymphocytic leukaemia, and recombinant Factor IX blood clotting protein. BTG operates through wholly owned subsidiaries BTG International Ltd and BTG International Inc in the UK and USA, respectively."

For those of you wondering about BTG acquiring licensing rights for Clone-3 from BioClonetics back in 2002, here's my take on this:

BTS no longer exists for reason they were acquired by Boston Scientific. In order for Boston Scientific to have licensing rights to Clone-3 they would need to obtain it directly from BioClonetics.

As far as I know Patent Licensing rights are NOT transferable unless it has been specifically stated in the Licensing Agreement which I doubt very seriously. If that was the case it would be well known by now after 18 years that Boston Scientific has been working on bringing Clone-3 technology to market. To date there is ZERO information in public that associates Boston Scientific with Clone-3.

I hope this makes sense.

Be well and prosper...